NextCure, Inc.NXTCNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank26
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P26
Within normal range
vs 5Y Ago
-0.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-21.86%
Q3 202572.40%
Q2 2025-74.80%
Q1 2025-87.37%
Q4 202440.34%
Q3 2024-15.35%
Q2 202420.30%
Q1 2024-18.35%
Q4 202318.18%
Q3 202313.11%
Q2 20230.00%
Q1 2023-53.12%
Q4 202236.82%
Q3 2022-4.23%
Q2 20225.39%
Q1 2022-10.35%
Q4 2021-7.99%
Q3 202124.19%
Q2 2021-18.79%
Q1 2021-102.22%
Q4 202058.63%
Q3 2020-15.11%
Q2 2020-26.61%
Q1 2020-11.42%
Q4 2019-28.07%
Q3 201928.12%
Q2 2019-46.44%
Q1 2019-138.97%
Q4 2018509.29%
Q3 20185.99%
Q2 2018-1.46%
Q1 20180.00%